4.4 Article

A somatic cell defect is associated with the onset of neurological symptoms in a lysosomal storage disease

Journal

MOLECULAR GENETICS AND METABOLISM
Volume 110, Issue 1-2, Pages 188-190

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymgme.2013.06.010

Keywords

Niemann-Pick disease, type C1; NPC1; Lysosomal storage disorders; Neurodegenerative disorders

Funding

  1. National Human Genome Research Institute, National Institutes of Health
  2. Eunice Kennedy Shriver National Institute of Child Health and Human Development
  3. Ara Parseghian Medical Research Foundation
  4. Office of Rare Diseases
  5. National Institutes of Health Clinical Center
  6. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000139, ZIAHD008824] Funding Source: NIH RePORTER
  7. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000068, ZICHG200350] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Mutations in individuals with the lysosomal storage disorder Niemann-Pick disease, type C1 (NPC1) are heterogeneous, not localized to specific protein domains, and not correlated to time of onset or disease severity. We demonstrate direct correlation of the time of neurological symptom onset with the severity of lysosomal defects in NPC1 patient-derived fibroblasts. This is a novel assay for NPC1 individuals that may be predictive of NPC1 disease progression and broadly applicable to other lysosomal disorders. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available